What is the recommended emergency management for a patient presenting with shortness of breath, heart rate 138 bpm, known atrial fibrillation, and no chest pain or limb swelling?

Emergency Management of AF with Rapid Ventricular Response and Shortness of Breath

For this patient with known AF, HR 138, and shortness of breath without hemodynamic instability, immediately initiate intravenous beta-blockers (metoprolol, esmolol, or propranolol) or non-dihydropyridine calcium channel blockers (diltiazem or verapamil) for acute rate control. 1

Immediate Assessment and Triage

First, determine hemodynamic stability:

• Unstable signs: Symptomatic hypotension, acute heart failure not responding to pharmacological measures, ongoing chest pain/MI, or pulmonary edema → immediate electrical cardioversion 2
• Stable but symptomatic (your patient): Proceed with pharmacological rate control

Since your patient has shortness of breath but no chest pain or signs of acute decompensation (no limb swelling suggesting volume overload), they fall into the stable but symptomatic category requiring urgent rate control.

Rate Control Strategy (First-Line for Stable Patients)

Intravenous options for acute rate control:

1. Beta-blockers (preferred if no contraindications):

   • Metoprolol 2.5-5 mg IV bolus over 2 minutes, repeat every 5-10 minutes up to 15 mg
   • Esmolol 500 mcg/kg loading dose, then 50-200 mcg/kg/min infusion
   • Caution: Avoid in acute heart failure with reduced ejection fraction 1

2. Calcium channel blockers (alternative):

   • Diltiazem 0.25 mg/kg IV over 2 minutes, then 5-15 mg/hr infusion
   • Verapamil 5-10 mg IV over 2 minutes
   • Caution: Exercise caution in hypotension or heart failure 1

3. If heart failure is present:

   • Use digoxin or amiodarone IV instead of beta-blockers or calcium channel blockers 1
   • Digoxin: 0.25 mg IV, repeat in 2-4 hours if needed (slower onset, 2+ hours)
   • Amiodarone: 150 mg IV over 10 minutes, then 1 mg/min for 6 hours

Critical Decision Points

Assess for underlying precipitants causing the rapid rate:

• Pulmonary embolism (explains SOB without chest pain or swelling)
• Infection/sepsis
• Thyrotoxicosis
• Acute coronary syndrome
• Medication non-compliance
• Alcohol use

The absence of limb swelling argues against DVT/PE but doesn't exclude it - consider D-dimer, troponin, chest X-ray, and ECG as baseline workup.

Anticoagulation Considerations

Since this is known AF (not new-onset), verify anticoagulation status:

• If already anticoagulated and therapeutic → continue
• If not anticoagulated → initiate anticoagulation immediately unless contraindicated 2
• Target INR 2.0-3.0 for warfarin, or use direct oral anticoagulant 2

Do not delay anticoagulation - the 2024 ESC guidelines emphasize stroke prevention as a core component of AF management 3.

Rhythm Control vs. Rate Control Decision

For this acute presentation, rate control is the initial priority. Consider rhythm control (cardioversion) only if:

• Symptoms persist despite adequate rate control
• Recent onset (<48 hours) AND patient desires rhythm control
• Hemodynamic compromise develops

If AF duration >48 hours or unknown (likely in known AF):

• Requires 3-4 weeks of therapeutic anticoagulation before elective cardioversion 2
• OR transesophageal echo to rule out left atrial thrombus before cardioversion 2

Target Heart Rate

Goal: Resting HR <110 bpm initially (lenient control acceptable for most patients) 1

• Reassess during activity/exercise - adjust medications to keep rate physiological during exertion 1
• Combination therapy (digoxin + beta-blocker or calcium channel blocker) may be needed for optimal control at rest and exercise 2, 1

Common Pitfalls to Avoid

1. Never use digoxin as sole agent for acute rate control in paroxysmal AF - onset too slow 2
2. Avoid beta-blockers and calcium channel blockers if WPW/pre-excitation suspected (wide QRS in AF) - can precipitate ventricular fibrillation 2
3. Don't cardiovert without anticoagulation unless truly hemodynamically unstable 2
4. Exercise caution with IV rate control agents in hypotension - may worsen hemodynamics 1

Disposition

After achieving rate control:

• Admit if: First episode, unclear etiology, inadequate rate control, need for cardioversion, significant comorbidities, or social factors preventing safe discharge
• Consider discharge if: Known AF, rate controlled, therapeutic anticoagulation confirmed, reliable follow-up arranged, and patient educated on warning signs 4, 5

The 2024 ESC guidelines emphasize the AF-CARE pathway (Comorbidities, Avoidance of stroke, Rate/rhythm control, Evaluation) as a holistic approach 3, 6, but in the acute ED setting, your immediate priorities are rate control and ensuring anticoagulation.